The active humidifier devices market generated a revenue of US$ 1,558.6 million in 2022. It is gradually declining at a (-) 0.5% CAGR, thus recording US$ 1,264.4 million in 2023. By 2033, the market is expected to be contracted to US$ 1,206.9 million, as forecasted by Future Market Insights.
Demand for active humidifier devices is mostly driven by the increased prevalence of obstructive respiratory diseases. Due to the outbreak of previously unknown infectious diseases that affect respiratory systems, the adoption of active humidifier devices surged in the historical period. Further, the application of humidifier devices in invasive ventilation accounted for nearly 47% of sales in 2022.
| Attribute | Details |
|---|---|
| Active Humidifier Devices Market Size (2023) | US$ 1,264.4 million |
| Active Humidifier Devices Market Size (2033) | US$ 1,206.9 million |
| Active Humidifier Devices Industry CAGR (2023 to 2033) | -0.5% CAGR |
| Active Humidifier Devices Market Size (2022) | US$ 1,558.6 million |
| Active Humidifier Devices Market Size (2017) | US$ 442 million |
| Active Humidifier Devices Industry CAGR (2017 to 2022) | 28.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Refining healthcare infrastructure and surging medical expenditure by governments are expected to support to set up and usage of advanced medical devices across various institutes. These institutes include hospitals, ambulatory surgical centers, primary healthcare units, and sleep care institutes.
Technological advancements have led to the expanding use of active respiratory humidifiers across various applications across care. Apart from the general hospitals' wards to critical care units, bubble humidifiers are now being found compatible to be used in MRI settings.
Agreements, partnerships, and collaborations have surfaced as main growth strategies implemented by the leading players in the active humidifier devices industry. Followed by this, new product launches emerged as the second-leading strategy adopted by the key players in the market. Further, these strategies help the companies to expand their product offerings to enhance respiratory care. Acquisitions of key companies significantly accelerate the manufacturer’s plan to capture more market share.
Improvement and streamlining of regulatory processes in developing countries are expected to boost
The manufacturers are realizing the low returns in this market despite these opportunities, considering the gradually reducing market size. Without beneficial prospects, manufacturers are most likely to turn down development proposals.
Principal Consultant
According to Future Market Insights (FMI), the sales of active humidifier devices market expanded at a CAGR of 28.7% between 2018 and 2022. During this period, the growing respiratory distress due to the COVID-19 virus had created a sharp rise in the adoption of ventilators the world over.
Demand for active humidifier devices increased during the pandemic as humidifiers are deployed to offer humidified air to patients who need respiratory assistance. Increased demand for crucial life-saving instruments such as medical ventilators, and high-flow oxygen therapy devices due to the sudden outbreak of COVID-19 motivated the market growth in the historical period.
The emergence of infectious diseases affecting respiratory systems and acceptance of high-flow nasal cannulas for oxygen therapy is anticipated to sustain the sales of active humidifier devices over the forecast period. Moreover, demand for active humidifier devices is primarily driven by improving healthcare infrastructure, increasing medical expenditure, and the high prevalence of respiratory diseases across the globe.
Integration of technologically advanced new solutions to meet patients' expanding respiratory needs is a primary reason for the intense competition in the market worldwide. Leading companies are concentrating on product unveilings and innovations or obtaining approvals for their new products to generate reasonable revenues.
Key manufacturers in this industry are hit severely since COVID cases have petered out. According to Future Market Insights, the global active humidifier devices industry is poised to register a CAGR of -0.5% from 2023 to 2033.
| Historical CAGR (2018 to 2022) | 28.7% |
|---|---|
| Forecast CAGR (2023 to 2033) | -0.5% |
The market forecast is expected to be challenging for manufacturers, as the sales have been estimated to dwindle from US$ 1,264.4 million in 2023 to US$ 1,206.9 million by 2033.
The shriveling market size can be credited to the ease of COVID-19 cases. Other factors that are also contributing to the declining market include:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Country | The United States |
|---|---|
| Market Share % (2022) | 27.8% |
In 2022, the United States accounted for over 94% value share in North America. The need for active humidifier devices saw heightened demand in the United States due to the unprecedented outbreak of COVID-19.
A large number of patients suffering from COVID-19 have driven the need for active humidifier devices for survival. Due to the significant need for these devices, the market witnessed positive growth during the historical period.
The market is projected to be driven by rising affordability to treat respiratory diseases, an increasing number of tracheostomies executed for different diseases and health consciousness.
| Country | Germany |
|---|---|
| Market Share % (2022) | 4% |
Germany is expected to account for over 32.3% of the market in Europe by 2033, opines Future Market Insights. The rise in demand for active humidifier devices is primarily due to increasing health awareness.
The sudden outbreak of the COVID-19 epidemic increased the demand for active humidifier diseases to curb the increasing mortality rates due to the pandemic. Further, the technological advancements and the adoption of heated/electronic humidifier devices are likely to offer up new opportunities for the active humidifier devices industry players in Germany.
| Country | China |
|---|---|
| Market CAGR % (2023 to 2033) | 1.5% |
As per Future Market Insights, China’s active humidifier devices market is expected to account for over 49.5% of the market across East Asia by 2033. The high prevalence of respiratory diseases in the country is a key factor driving market growth.
Demand for active humidifier devices witnessed a sudden spike in the historical period as China was the first country to witness the spread of COVID-19. With surged cases, the need for active humidifier devices increased, spurring sales during that period.
In China, chronic respiratory diseases are the second leading cause of death. A few key factors propelling the market growth include a robust healthcare system and increasing healthcare expenditures and technological advancement.
| Country | India |
|---|---|
| Market CAGR % (2023 to 2033) | -1.3% |
The active humidifier devices market in India is likely to register a CAGR of -1.3% during the forecast period, with a market share of over 50% across South Asia, as per the latest report of FMI. The leading factor that aided the market growth is the outbreak of the COVID-19 pandemic.
India witnessed a sudden spike in cases in the second wave, due to which the government increased the adoption of active humidifier devices to reduce the fatalities in the country.
Cases of coronavirus have abated in the country, leading to reduced demand for active humidifier devices. As a result, the country offers reduced opportunities for future growth. By the end of the forecast period, the market is expected to return to pre-covid levels.
| Segment | Electronic Humidifiers |
|---|---|
| Market Share % (2022) | 55.79% |
With the advent of advanced technology and innovation in recent years, active humidifier devices are growing and have become one of the most significant sectors in the healthcare industry. Based on product type, heated/electronic humidifier devices are expected to lead the segment in the global market, occupying a market share of more than 55.79% by the end of 2023.
Demand for heated/electronic heaters is expected to increase over the coming years as electric humidifiers also help people with dry skin and allergies. Moreover, the high prevalence of airborne diseases such as flu, influenza, and other diseases has surged the adoption of heated/electronic humidifier devices.
Medical researchers found that humidity levels above 40% significantly deactivate the virus and bacteria that cause airborne respiratory diseases. Hence, adoption of these devices is expected to surge over the coming years.
| Segment | Invasive Ventilation |
|---|---|
| Market Share % (2022) | 47% |
By application, the market is segregated into non-invasive ventilation, invasive ventilation, and high-flow oxygen therapy. As per Future Market Insights, the invasive ventilation segment is expected to be the dominant segment in the global active humidifier devices market in 2023, occupying a market share of more than 47% in 2023.
Following the outbreak of COVID-19, as the cases increased at an alarming rate, especially in developing economies such as India, the need for invasive ventilation increased the sales of active humidifier devices. Also, the demand for non-invasive ventilation among the geriatric population is expected to increase over the coming years. The segment is projected to account for over 31.3% of the market share by 2033.
Companies operating in the global active humidifier devices industry seek to invigorate their position through collaborations, partnerships, and agreements with established and emerging market players. Further, the acquisition significantly accelerates the manufacturer’s strategy to capitalize on the market share and capture a significant share of the market.
Key Developments Taking Place in the Market:
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ million for Value, Units for Volume |
| Key Countries Covered | The United States, Canada, Germany, the United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, South Africa |
| Key Segments Covered | Product Type, Age Group, Application, End User, and Region |
| Key Companies Profiled | Fisher & Paykel Healthcare Limited; Koninklijke Philips N.V.(Philips Respironics); Vapotherm; Teleflex Corporation; ResMed Corporation; VINCENT MEDICAL HOLDINGS LIMITED; Armstrong Medical (an Eakin Company); Breas Medical AB (Subsidiary of Fosun Pharma); BMC Medical Co., Ltd; Hamilton Medical AG; SunMed; WILAmed GmbH; Flexicare (Group) Limited; Penlon Limited; DEAS S.R.L.; Intersurgical Ltd; Beijing Aeonmed Co., Ltd.; Shenyang RMS MEDICAL TECH CO., LTD; GaleMed Corporation; Vadi Medical Technology Co, Ltd. |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The active humidifier devices market CAGR for 2033 is -0.5%.
The market is estimated to reach US$ 1,206.9 million by 2033.
The challenges in the active humidifier devices market are the cost, maintenance, and risk of mold growth.
The market is estimated to secure a valuation of US$ 1,264.4 million in 2023.
Increasing demand for indoor air quality improvement is the key challenge.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Heated/electronic Humidifiers
5.3.2. Bubble Humidifiers
5.3.3. Accessories
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Age Group
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Age Group, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Age Group, 2023 to 2033
6.3.1. Adult
6.3.2. Paediatric
6.3.3. Neonates
6.4. Y-o-Y Growth Trend Analysis By Age Group, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Age Group, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033
7.3.1. Invasive Ventilation
7.3.2. Non-invasive Ventilation
7.3.2.1. nCPAP (Nasal Continuous Positive Airway Pressure)
7.3.2.2. Bubble CPAP (Bubble Continuous Positive Airway Pressure)
7.3.3. High Flow Oxygen Therapy
7.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022
8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
8.3.1. Hospitals
8.3.1.1. Less than 100 Beds
8.3.1.2. 100-300 Beds
8.3.1.3. 300-500 Beds
8.3.1.4. 500 Beds and More
8.3.2. Ambulatory Surgical Centers
8.3.3. Sleep Centres
8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
9.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Western Europe
9.3.4. Eastern Europe
9.3.5. South Asia and Pacific
9.3.6. East Asia
9.3.7. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. The USA
10.2.1.2. Canada
10.2.2. By Product Type
10.2.3. By Age Group
10.2.4. By Application
10.2.5. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Age Group
10.3.4. By Application
10.3.5. By End User
10.4. Key Takeaways
11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Product Type
11.2.3. By Age Group
11.2.4. By Application
11.2.5. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Age Group
11.3.4. By Application
11.3.5. By End User
11.4. Key Takeaways
12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. United Kingdom
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Rest of Western Europe
12.2.2. By Product Type
12.2.3. By Age Group
12.2.4. By Application
12.2.5. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Age Group
12.3.4. By Application
12.3.5. By End User
12.4. Key Takeaways
13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. Poland
13.2.1.2. Russia
13.2.1.3. Czech Republic
13.2.1.4. Romania
13.2.1.5. Rest of Eastern Europe
13.2.2. By Product Type
13.2.3. By Age Group
13.2.4. By Application
13.2.5. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Age Group
13.3.4. By Application
13.3.5. By End User
13.4. Key Takeaways
14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. India
14.2.1.2. Bangladesh
14.2.1.3. Australia
14.2.1.4. New Zealand
14.2.1.5. Rest of South Asia and Pacific
14.2.2. By Product Type
14.2.3. By Age Group
14.2.4. By Application
14.2.5. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Age Group
14.3.4. By Application
14.3.5. By End User
14.4. Key Takeaways
15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. China
15.2.1.2. Japan
15.2.1.3. South Korea
15.2.2. By Product Type
15.2.3. By Age Group
15.2.4. By Application
15.2.5. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Type
15.3.3. By Age Group
15.3.4. By Application
15.3.5. By End User
15.4. Key Takeaways
16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
16.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
16.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
16.2.1. By Country
16.2.1.1. GCC Countries
16.2.1.2. South Africa
16.2.1.3. Israel
16.2.1.4. Rest of MEA
16.2.2. By Product Type
16.2.3. By Age Group
16.2.4. By Application
16.2.5. By End User
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Product Type
16.3.3. By Age Group
16.3.4. By Application
16.3.5. By End User
16.4. Key Takeaways
17. Key Countries Market Analysis
17.1. USA
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2022
17.1.2.1. By Product Type
17.1.2.2. By Age Group
17.1.2.3. By Application
17.1.2.4. By End User
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2022
17.2.2.1. By Product Type
17.2.2.2. By Age Group
17.2.2.3. By Application
17.2.2.4. By End User
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2022
17.3.2.1. By Product Type
17.3.2.2. By Age Group
17.3.2.3. By Application
17.3.2.4. By End User
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2022
17.4.2.1. By Product Type
17.4.2.2. By Age Group
17.4.2.3. By Application
17.4.2.4. By End User
17.5. Germany
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2022
17.5.2.1. By Product Type
17.5.2.2. By Age Group
17.5.2.3. By Application
17.5.2.4. By End User
17.6. United Kingdom
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2022
17.6.2.1. By Product Type
17.6.2.2. By Age Group
17.6.2.3. By Application
17.6.2.4. By End User
17.7. France
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2022
17.7.2.1. By Product Type
17.7.2.2. By Age Group
17.7.2.3. By Application
17.7.2.4. By End User
17.8. Spain
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2022
17.8.2.1. By Product Type
17.8.2.2. By Age Group
17.8.2.3. By Application
17.8.2.4. By End User
17.9. Italy
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2022
17.9.2.1. By Product Type
17.9.2.2. By Age Group
17.9.2.3. By Application
17.9.2.4. By End User
17.10. Poland
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2022
17.10.2.1. By Product Type
17.10.2.2. By Age Group
17.10.2.3. By Application
17.10.2.4. By End User
17.11. Russia
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2022
17.11.2.1. By Product Type
17.11.2.2. By Age Group
17.11.2.3. By Application
17.11.2.4. By End User
17.12. Czech Republic
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2022
17.12.2.1. By Product Type
17.12.2.2. By Age Group
17.12.2.3. By Application
17.12.2.4. By End User
17.13. Romania
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2022
17.13.2.1. By Product Type
17.13.2.2. By Age Group
17.13.2.3. By Application
17.13.2.4. By End User
17.14. India
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2022
17.14.2.1. By Product Type
17.14.2.2. By Age Group
17.14.2.3. By Application
17.14.2.4. By End User
17.15. Bangladesh
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2022
17.15.2.1. By Product Type
17.15.2.2. By Age Group
17.15.2.3. By Application
17.15.2.4. By End User
17.16. Australia
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2022
17.16.2.1. By Product Type
17.16.2.2. By Age Group
17.16.2.3. By Application
17.16.2.4. By End User
17.17. New Zealand
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2022
17.17.2.1. By Product Type
17.17.2.2. By Age Group
17.17.2.3. By Application
17.17.2.4. By End User
17.18. China
17.18.1. Pricing Analysis
17.18.2. Market Share Analysis, 2022
17.18.2.1. By Product Type
17.18.2.2. By Age Group
17.18.2.3. By Application
17.18.2.4. By End User
17.19. Japan
17.19.1. Pricing Analysis
17.19.2. Market Share Analysis, 2022
17.19.2.1. By Product Type
17.19.2.2. By Age Group
17.19.2.3. By Application
17.19.2.4. By End User
17.20. South Korea
17.20.1. Pricing Analysis
17.20.2. Market Share Analysis, 2022
17.20.2.1. By Product Type
17.20.2.2. By Age Group
17.20.2.3. By Application
17.20.2.4. By End User
17.21. GCC Countries
17.21.1. Pricing Analysis
17.21.2. Market Share Analysis, 2022
17.21.2.1. By Product Type
17.21.2.2. By Age Group
17.21.2.3. By Application
17.21.2.4. By End User
17.22. South Africa
17.22.1. Pricing Analysis
17.22.2. Market Share Analysis, 2022
17.22.2.1. By Product Type
17.22.2.2. By Age Group
17.22.2.3. By Application
17.22.2.4. By End User
17.23. Israel
17.23.1. Pricing Analysis
17.23.2. Market Share Analysis, 2022
17.23.2.1. By Product Type
17.23.2.2. By Age Group
17.23.2.3. By Application
17.23.2.4. By End User
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Product Type
18.3.3. By Age Group
18.3.4. By Application
18.3.5. By End User
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. Fisher & Paykel Healthcare Limited
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.1.5.2. Product Strategy
19.1.1.5.3. Channel Strategy
19.1.2. Koninklijke Philips N.V.(Philips Respironics)
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.2.5.2. Product Strategy
19.1.2.5.3. Channel Strategy
19.1.3. Vapotherm
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.3.5.2. Product Strategy
19.1.3.5.3. Channel Strategy
19.1.4. Teleflex Corporation
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.4.5.2. Product Strategy
19.1.4.5.3. Channel Strategy
19.1.5. ResMed Corporation
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.5.5.2. Product Strategy
19.1.5.5.3. Channel Strategy
19.1.6. VINCENT MEDICAL HOLDINGS LIMITED
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.6.5.2. Product Strategy
19.1.6.5.3. Channel Strategy
19.1.7. Armstrong Medical (an Eakin Company)
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.7.5.2. Product Strategy
19.1.7.5.3. Channel Strategy
19.1.8. Breas Medical AB (Subsidiary of Fosun Pharma)
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.8.5.2. Product Strategy
19.1.8.5.3. Channel Strategy
19.1.9. BMC Medical Co., Ltd
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.9.5.2. Product Strategy
19.1.9.5.3. Channel Strategy
19.1.10. Hamilton Medical AG
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
19.1.10.5.2. Product Strategy
19.1.10.5.3. Channel Strategy
19.1.11. SunMed
19.1.11.1. Overview
19.1.11.2. Product Portfolio
19.1.11.3. Profitability by Market Segments
19.1.11.4. Sales Footprint
19.1.11.5. Strategy Overview
19.1.11.5.1. Marketing Strategy
19.1.11.5.2. Product Strategy
19.1.11.5.3. Channel Strategy
19.1.12. WILAmed GmbH
19.1.12.1. Overview
19.1.12.2. Product Portfolio
19.1.12.3. Profitability by Market Segments
19.1.12.4. Sales Footprint
19.1.12.5. Strategy Overview
19.1.12.5.1. Marketing Strategy
19.1.12.5.2. Product Strategy
19.1.12.5.3. Channel Strategy
19.1.13. Flexicare (Group) Limited
19.1.13.1. Overview
19.1.13.2. Product Portfolio
19.1.13.3. Profitability by Market Segments
19.1.13.4. Sales Footprint
19.1.13.5. Strategy Overview
19.1.13.5.1. Marketing Strategy
19.1.13.5.2. Product Strategy
19.1.13.5.3. Channel Strategy
19.1.14. Penlon Limited
19.1.14.1. Overview
19.1.14.2. Product Portfolio
19.1.14.3. Profitability by Market Segments
19.1.14.4. Sales Footprint
19.1.14.5. Strategy Overview
19.1.14.5.1. Marketing Strategy
19.1.14.5.2. Product Strategy
19.1.14.5.3. Channel Strategy
19.1.15. DEAS S.R.L.
19.1.15.1. Overview
19.1.15.2. Product Portfolio
19.1.15.3. Profitability by Market Segments
19.1.15.4. Sales Footprint
19.1.15.5. Strategy Overview
19.1.15.5.1. Marketing Strategy
19.1.15.5.2. Product Strategy
19.1.15.5.3. Channel Strategy
19.1.16. Intersurgical Ltd
19.1.16.1. Overview
19.1.16.2. Product Portfolio
19.1.16.3. Profitability by Market Segments
19.1.16.4. Sales Footprint
19.1.16.5. Strategy Overview
19.1.16.5.1. Marketing Strategy
19.1.16.5.2. Product Strategy
19.1.16.5.3. Channel Strategy
19.1.17. Beijing Aeonmed Co., Ltd.
19.1.17.1. Overview
19.1.17.2. Product Portfolio
19.1.17.3. Profitability by Market Segments
19.1.17.4. Sales Footprint
19.1.17.5. Strategy Overview
19.1.17.5.1. Marketing Strategy
19.1.17.5.2. Product Strategy
19.1.17.5.3. Channel Strategy
19.1.18. Shenyang RMS MEDICAL TECH CO., LTD
19.1.18.1. Overview
19.1.18.2. Product Portfolio
19.1.18.3. Profitability by Market Segments
19.1.18.4. Sales Footprint
19.1.18.5. Strategy Overview
19.1.18.5.1. Marketing Strategy
19.1.18.5.2. Product Strategy
19.1.18.5.3. Channel Strategy
19.1.19. GaleMed Corporation
19.1.19.1. Overview
19.1.19.2. Product Portfolio
19.1.19.3. Profitability by Market Segments
19.1.19.4. Sales Footprint
19.1.19.5. Strategy Overview
19.1.19.5.1. Marketing Strategy
19.1.19.5.2. Product Strategy
19.1.19.5.3. Channel Strategy
19.1.20. Vadi Medical Technology Co, Ltd.
19.1.20.1. Overview
19.1.20.2. Product Portfolio
19.1.20.3. Profitability by Market Segments
19.1.20.4. Sales Footprint
19.1.20.5. Strategy Overview
19.1.20.5.1. Marketing Strategy
19.1.20.5.2. Product Strategy
19.1.20.5.3. Channel Strategy
20. Assumptions & Acronyms Used
21. Research Methodology
Explore Healthcare Insights
View Reports
Active Humidifier Devices Market
